3 completed, 1 terminated. 2 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Neprilysin: new trials by email Literature Review of Neprilysin trials Research Report on Neprilysin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multiple-Dose Study of LY3493269 in Healthy Participants LY3493269, Sodium Caprate (C10), Salcaprozate Sodium (SNAC) - Healthy | Phase 1 | Terminated | Eli Lilly and Company | 42 | 2023-03-23 | 2025-01-14 |
| The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure Neprilysin, Enalapril - Heart Failure, Exercise Tolerance | Phase 4 | Completed | University of Sao Paulo General Hospital | 52 | 2017-06-14 | 2020-10-22 |
| Comparing the Ketogenic Effect of Coconut Oil and Different MCTs Coconut oil, Coconut oil + MCT, MCT - Healthy Adults | Not applicable | Completed | Université de Sherbrooke | 10 | 2015-06-01 | 2020-04-06 |
| Body Fat Distribution and Fat Metabolism Long-chain (C18:2) and medium chain fatty acid (C8 and C10). - Obesity, Metabolic Disease | Not applicable | Completed | TNO | 12 | 2007-05-01 | 2008-04-07 |
Aneurysm (1) · Heart Failure (1) · Ketosis (1) · Metabolic Diseases (1) · Obesity (1)
Eli Lilly and Company (1) · TNO (1) · University of Sao Paulo General Hospital (1) · Université de Sherbrooke (1)
Brazil (1) · Canada (1) · Netherlands (1) · Singapore (1)
Antonio P Barretto, PhD (1) · Stephen Cunnane, PhD (1) · Wilrike Pasman, PhD (1)